Seyedeh Yasaman Alemohammad, Amirmohammad Khalaji, Olatokunbo Osibogun, Rime Jebai, Wei Li, Ateeqa Ijaz, Miranda Gehris, Ghader Dargahi Abbasabad, Kenneth Ward, Zoran Bursac, Ziyad Ben Taleb, Mohammad Ebrahimi Kalan
{"title":"Associations between ENDS and cigarette use, and compromised immunity in US adults: Findings from the 2021-2022 NHIS.","authors":"Seyedeh Yasaman Alemohammad, Amirmohammad Khalaji, Olatokunbo Osibogun, Rime Jebai, Wei Li, Ateeqa Ijaz, Miranda Gehris, Ghader Dargahi Abbasabad, Kenneth Ward, Zoran Bursac, Ziyad Ben Taleb, Mohammad Ebrahimi Kalan","doi":"10.1080/10550887.2024.2380116","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Tobacco use presents increased risks for individuals with weakened immune systems (WIS). We investigated the association between cigarette and electronic nicotine delivery systems (ENDS or e-cigarettes) use and WIS in US adults using data from the 2021-2022 National Health Interview Survey.</p><p><strong>Methods: </strong>Data from 57,133 adults were analyzed, focusing on WIS prevalence due to health conditions, prescriptions, or both. Cigarette and ENDS use were categorized as never, former, or current. Weighted multivariable regression models adjusted for demographics and other health conditions to assess associations between tobacco use and WIS.</p><p><strong>Results: </strong>Among US adults, 4.3% had prescription-related WIS, 4.6% had health condition-related WIS, and 7% had WIS due to either reason. Adjusted results from multivariable regression models indicated that adults with WIS due to health conditions were more likely to be current (AOR = 1.21, 95%CI: 1.05-1.40) and former (AOR = 1.25, 95%CI: 1.11-1.39) cigarette smokers compared to counterparts without WIS. Adults with WIS due to prescriptions were more likely to be former cigarette smokers (AOR = 1.19, 95%CI: 1.06-1.34). Those with WIS for any reason were more likely to be current (AOR = 1.19, 95%CI: 1.05-1.35) and former (AOR = 1.24, 95%CI: 1.13-1.36) cigarette smokers. Adults with WIS due to health conditions (AOR = 1.23, 95%CI: 1.06-1.41) or any reasons (AOR = 1.19, 95%CI:1.05-1.34) were more likely to be former ENDS users compared to those without WIS.</p><p><strong>Conclusions: </strong>In this nationally representative study, we found a notable link between cigarette and ENDS use with WIS, particularly among those with health condition-related or prescription-related WIS, underscoring the importance of addressing tobacco use in this vulnerable population.</p>","PeriodicalId":47493,"journal":{"name":"Journal of Addictive Diseases","volume":" ","pages":"1-10"},"PeriodicalIF":1.6000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Addictive Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10550887.2024.2380116","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Tobacco use presents increased risks for individuals with weakened immune systems (WIS). We investigated the association between cigarette and electronic nicotine delivery systems (ENDS or e-cigarettes) use and WIS in US adults using data from the 2021-2022 National Health Interview Survey.
Methods: Data from 57,133 adults were analyzed, focusing on WIS prevalence due to health conditions, prescriptions, or both. Cigarette and ENDS use were categorized as never, former, or current. Weighted multivariable regression models adjusted for demographics and other health conditions to assess associations between tobacco use and WIS.
Results: Among US adults, 4.3% had prescription-related WIS, 4.6% had health condition-related WIS, and 7% had WIS due to either reason. Adjusted results from multivariable regression models indicated that adults with WIS due to health conditions were more likely to be current (AOR = 1.21, 95%CI: 1.05-1.40) and former (AOR = 1.25, 95%CI: 1.11-1.39) cigarette smokers compared to counterparts without WIS. Adults with WIS due to prescriptions were more likely to be former cigarette smokers (AOR = 1.19, 95%CI: 1.06-1.34). Those with WIS for any reason were more likely to be current (AOR = 1.19, 95%CI: 1.05-1.35) and former (AOR = 1.24, 95%CI: 1.13-1.36) cigarette smokers. Adults with WIS due to health conditions (AOR = 1.23, 95%CI: 1.06-1.41) or any reasons (AOR = 1.19, 95%CI:1.05-1.34) were more likely to be former ENDS users compared to those without WIS.
Conclusions: In this nationally representative study, we found a notable link between cigarette and ENDS use with WIS, particularly among those with health condition-related or prescription-related WIS, underscoring the importance of addressing tobacco use in this vulnerable population.
背景:吸烟会增加免疫力低下者(WIS)的风险。我们利用 2021-2022 年全国健康访谈调查(National Health Interview Survey)的数据,研究了美国成年人使用香烟和电子尼古丁输送系统(ENDS 或电子烟)与 WIS 之间的关系:对 57,133 名成年人的数据进行了分析,重点关注因健康状况、处方或两者导致的 WIS 患病率。香烟和 ENDS 的使用分为从未使用、曾经使用和目前使用。加权多变量回归模型对人口统计学和其他健康状况进行了调整,以评估烟草使用与WIS之间的关联:结果:在美国成年人中,4.3%的人的WIS与处方有关,4.6%的人的WIS与健康状况有关,7%的人的WIS与其中任何一个原因有关。多变量回归模型的调整结果表明,与没有 WIS 的成年人相比,因健康状况而有 WIS 的成年人更有可能现在吸烟(AOR = 1.21,95%CI:1.05-1.40)和曾经吸烟(AOR = 1.25,95%CI:1.11-1.39)。因处方而患有 WIS 的成年人更有可能曾经吸烟(AOR = 1.19,95%CI:1.06-1.34)。因任何原因而患有 WIS 的人更有可能是当前吸烟者(AOR = 1.19,95%CI:1.05-1.35)和曾经吸烟者(AOR = 1.24,95%CI:1.13-1.36)。因健康状况(AOR = 1.23,95%CI:1.06-1.41)或任何原因(AOR = 1.19,95%CI:1.05-1.34)而使用 WIS 的成年人与未使用 WIS 的成年人相比,更有可能曾经使用过 ENDS:在这项具有全国代表性的研究中,我们发现卷烟和ENDS的使用与WIS之间存在明显的联系,尤其是在那些与健康状况相关或与处方相关的WIS人群中,这强调了解决这一弱势群体烟草使用问题的重要性。
期刊介绍:
The Journal of Addictive Diseases is an essential, comprehensive resource covering the full range of addictions for today"s addiction professional. This in-depth, practical journal helps you stay on top of the vital issues and the clinical skills necessary to ensure effective practice. The latest research, treatments, and public policy issues in addiction medicine are presented in a fully integrated, multi-specialty perspective. Top researchers and respected leaders in addiction issues share their knowledge and insights to keep you up-to-date on the most important research and practical applications.